61 related articles for article (PubMed ID: 21172161)
1. [Study on the value of tumor markers ProGRP, CYFRA21-1, NSE and CEA in the differential diagnosis of pleural effusion].
Liu Y; Yu L; Lin J
Zhongguo Fei Ai Za Zhi; 2006 Jun; 9(3):273-6. PubMed ID: 21172161
[TBL] [Abstract][Full Text] [Related]
2. Use of tumor markers in distinguishing lung adenocarcinoma-associated malignant pleural effusion from tuberculous pleural effusion.
Ai L; Wang W; Li J; Ye T; Li Y
Am J Med Sci; 2024 Apr; ():. PubMed ID: 38583522
[TBL] [Abstract][Full Text] [Related]
3. Application Value of CYFRA21-1 Combined with NSE, CEA, and SCC-Ag in Lung Cancer.
Fu Y; Li D; Zhu Y; Yan S; Wang X; Lian Z; Xie Q; He Z
Clin Lab; 2024 Apr; 70(4):. PubMed ID: 38623667
[TBL] [Abstract][Full Text] [Related]
4. Improvement of differential diagnosis of lung cancer by use of multiple protein tumor marker combinations.
Trulson I; Klawonn F; von Pawel J; Holdenrieder S
Tumour Biol; 2024; 46(s1):S81-S98. PubMed ID: 38277317
[TBL] [Abstract][Full Text] [Related]
5. Detection of CEA and ProGRP Levels in BALF of Patients with Peripheral Lung Cancer and Their Relationship with CT Signs.
Tian K; Li Z; Qin L
Biomed Res Int; 2022; 2022():4119912. PubMed ID: 35937401
[TBL] [Abstract][Full Text] [Related]
6. Comparison of serum tumor markers combined with dual-source CT in the diagnosis of lung cancer.
Shan Y; Yin X; Zhao N; Wang J; Yang S
Minerva Med; 2023 Dec; 114(6):795-801. PubMed ID: 33764713
[TBL] [Abstract][Full Text] [Related]
7. Exploring the application value of pro-gastrin-releasing peptide in the clinical diagnosis and surgical treatment of medullary thyroid carcinoma.
Miao Q; Lv X; Luo L; Zhang J; Cai B
Cancer Med; 2023 Oct; 12(19):19576-19582. PubMed ID: 37754747
[TBL] [Abstract][Full Text] [Related]
8. Clinical Value of Pleural Effusion and Serum MMP-3 and CYFRA21-1 Combined with ADA in Differential Diagnosis of Pleural Exudative Effusion.
Xu Z; Guan J; Xu J; Tu J; Cheng J
Emerg Med Int; 2022; 2022():1615058. PubMed ID: 36072615
[TBL] [Abstract][Full Text] [Related]
9. [Diagnostic values of conventional tumor markers and their combination with chest CT for patients with stageⅠA lung cancer].
Peng Q; Wu N; Huang Y; Zhao SJ; Tang W; Liang M; Ran YL; Xiao T; Yang L; Liang X
Zhonghua Zhong Liu Za Zhi; 2023 Nov; 45(11):934-941. PubMed ID: 37968078
[No Abstract] [Full Text] [Related]
10. Human epididymal protein 4 and its combined detection show good diagnostic value in lung cancer: A retrospective study.
Wu L; Chen X; Peng T; Tang E; Bai W; Chen L
Int J Biol Markers; 2024 Jun; 39(2):141-148. PubMed ID: 38619974
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic potential of protein serum biomarkers for distinguishing small and non-small cell lung cancer in patients with suspicious lung lesions.
Sua LF; Serrano-Gomez SJ; Nuñez M; Amezquita-Dussan MA; Fernández-Trujillo L
Biomarkers; 2024 May; ():1-13. PubMed ID: 38804910
[TBL] [Abstract][Full Text] [Related]
12. Enhancing Diagnostic Accuracy for Lung Cancer through Combined Detection of Multiple Tumor Markers.
Qing G; Jiang X; Xu G; Liu T; Deng T
Altern Ther Health Med; 2023 Nov; 29(8):36-41. PubMed ID: 37632966
[TBL] [Abstract][Full Text] [Related]
13. A simple and efficient clinical prediction scoring system to identify malignant pleural effusion.
Wang S; An J; Hu X; Zeng T; Li P; Qin J; Shen Y; Wang T; Wen F
Ther Adv Respir Dis; 2024; 18():17534666231223002. PubMed ID: 38189181
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic Value of Imaging Combined With Tumor Markers in Early Detection of Lung Cancer.
Wei SJ; Wang LP; Wang JY; Ma JX; Chuan FB; Zhang YD
Front Surg; 2021; 8():694210. PubMed ID: 34901134
[No Abstract] [Full Text] [Related]
15. Improved diagnostic accuracy with three lung tumor markers compared to six-marker panel.
Izawa A; Hara Y; Horita N; Muraoka S; Kaneko M; Kaneko A; Somekawa K; Hirata M; Otsu Y; Matsumoto H; Nagasawa R; Tanaka K; Kubo S; Murohashi K; Aoki A; Fujii H; Watanabe K; Kobayashi N; Miura K; Nakajima H; Kaneko T
Transl Lung Cancer Res; 2024 Mar; 13(3):503-511. PubMed ID: 38601457
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and Safety of PD-1/PD-L1 Inhibitor and Chemotherapy in Treatment of Advanced Small Cell Lung Cancer.
Tian W; Zhao J; Wang W; Li Y
Altern Ther Health Med; 2023 Nov; ():. PubMed ID: 37971453
[TBL] [Abstract][Full Text] [Related]
17. The Usefulness of the Ratio of Antigen-Autoantibody Immune Complexes to Their Free Antigens in the Diagnosis of Non-Small Cell Lung Cancer.
Kim H; Lee JK; Oh AC; Kim HR; Hong YJ
Diagnostics (Basel); 2023 Sep; 13(18):. PubMed ID: 37761366
[TBL] [Abstract][Full Text] [Related]
18. Analysis of influencing factors of serum SCCA elevation in 309 CAP patients with normal CEA,NSE and CYFRA21-1.
Wang J; Tang X; Liu X; Zhang J
Front Oncol; 2024; 14():1243432. PubMed ID: 38347831
[TBL] [Abstract][Full Text] [Related]
19. The Diagnosis of Malignant Pleural Effusion Using Tumor-Marker Combinations: A Cost-Effectiveness Analysis Based on a Stacking Model.
Wang J; Zhou J; Wu H; Chen Y; Liang B
Diagnostics (Basel); 2023 Oct; 13(19):. PubMed ID: 37835879
[TBL] [Abstract][Full Text] [Related]
20. Association of serum tumor markers with serous effusion in systemic lupus erythematosus.
Zhong Y; Ma J; Zhang L; Liu Z; Xue L
Heliyon; 2023 Dec; 9(12):e23213. PubMed ID: 38144302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
